• Je něco špatně v tomto záznamu ?

A haemochromatosis-causing HFE mutation is associated with SARS-CoV-2 susceptibility in the Czech population

JA. Hubacek, T. Philipp, V. Adamkova, O. Majek, L. Dusek

. 2023 ; 538 (-) : 211-215. [pub] 20221224

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23004721

BACKGROUND: Coronavirus disease (COVID-19), which is caused by the SARS-CoV-2 virus, has become a global pandemic. While susceptibility to COVID-19 is subject to several external factors, including hypertension, BMI, and the presence of diabetes, it is also genetically determined to a significant extent. Infectious agents require iron (Fe) for proper functioning. Carriers of mutations resulting in increased iron concentrations are understood to be at increased risk of COVID-19. METHODS: We examined HFE genotypes associated with hereditary haemochromatosis (rs1800562 and rs1799945 SNPs) in 617 COVID-19 patients (166 asymptomatic, 246 symptomatic and 205 hospitalised survivors) and 2 559 population-based controls. RESULTS: We found a higher frequency of the minor allele (Tyr282) of the rs1800562 polymorphism (P < 0.002) in patients compared to controls (8.5 % vs 5.5 %). Non-carriers of the minor allele were protected against SARS-Cov-2 infection (OR, 95 %CI; 0.59, 0.42-0.82). The frequency of minor allele carriers was almost identical across asymptomatic, symptomatic, and hospitalised survivors. The rs1799945 variant did not affect disease severity and its occurrence was almost identical in patients and controls (P between 0.58 and 0.84). CONCLUSIONS: In conclusion, our results indicate that presence of the rs1800562 minor allele, which is associated with hereditary haemochromatosis (thus increased levels of plasma Fe), increases susceptibility to SARS-CoV-2.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004721
003      
CZ-PrNML
005      
20230425171659.0
007      
ta
008      
230418s2023 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.cca.2022.12.025 $2 doi
035    __
$a (PubMed)36572138
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Hubacek, J A $u Experimental Medicine Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Department of Endocrinology and Metabolism, Third Department of Internal Medicine, First Faculty of Medicine, Charles University & General University Hospital, Prague, Czech Republic. Electronic address: jahb@ikem.cz
245    12
$a A haemochromatosis-causing HFE mutation is associated with SARS-CoV-2 susceptibility in the Czech population / $c JA. Hubacek, T. Philipp, V. Adamkova, O. Majek, L. Dusek
520    9_
$a BACKGROUND: Coronavirus disease (COVID-19), which is caused by the SARS-CoV-2 virus, has become a global pandemic. While susceptibility to COVID-19 is subject to several external factors, including hypertension, BMI, and the presence of diabetes, it is also genetically determined to a significant extent. Infectious agents require iron (Fe) for proper functioning. Carriers of mutations resulting in increased iron concentrations are understood to be at increased risk of COVID-19. METHODS: We examined HFE genotypes associated with hereditary haemochromatosis (rs1800562 and rs1799945 SNPs) in 617 COVID-19 patients (166 asymptomatic, 246 symptomatic and 205 hospitalised survivors) and 2 559 population-based controls. RESULTS: We found a higher frequency of the minor allele (Tyr282) of the rs1800562 polymorphism (P < 0.002) in patients compared to controls (8.5 % vs 5.5 %). Non-carriers of the minor allele were protected against SARS-Cov-2 infection (OR, 95 %CI; 0.59, 0.42-0.82). The frequency of minor allele carriers was almost identical across asymptomatic, symptomatic, and hospitalised survivors. The rs1799945 variant did not affect disease severity and its occurrence was almost identical in patients and controls (P between 0.58 and 0.84). CONCLUSIONS: In conclusion, our results indicate that presence of the rs1800562 minor allele, which is associated with hereditary haemochromatosis (thus increased levels of plasma Fe), increases susceptibility to SARS-CoV-2.
650    _2
$a lidé $7 D006801
650    12
$a hemochromatóza $x genetika $x epidemiologie $7 D006432
650    _2
$a SARS-CoV-2 $7 D000086402
650    _2
$a MHC antigeny I. třídy $x genetika $7 D015395
650    _2
$a protein hemochromatózy $x genetika $7 D000071020
650    12
$a COVID-19 $x genetika $7 D000086382
650    _2
$a železo $7 D007501
650    _2
$a mutace $7 D009154
650    _2
$a jednonukleotidový polymorfismus $7 D020641
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Philipp, T $u Clinic of Rheumatology and Physiotherapy, Third Faculty of Medicine, Charles University & Thomayer University Hospital, Prague, Czech Republic
700    1_
$a Adamkova, V $u Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Majek, O $u Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Dusek, L $u Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
773    0_
$w MED00009464 $t Clinica chimica acta; international journal of clinical chemistry $x 1873-3492 $g Roč. 538, č. - (2023), s. 211-215
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36572138 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425171656 $b ABA008
999    __
$a ok $b bmc $g 1925046 $s 1190930
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 538 $c - $d 211-215 $e 20221224 $i 1873-3492 $m Clinica chimica acta $n Clin Chim Acta $x MED00009464
LZP    __
$a Pubmed-20230418

Najít záznam

Citační ukazatele

Možnosti archivace